Oppilotech and Evariste Technologies Announce Partnership to Develop First-in-Class Antibacterial Programme

Corporate Breaking News

Home : Oppilotech and Evariste Technologies Announce Partnership to Develop First-in-Class Antibacterial Programme

Mar 16 2022	Oppilotech and Evariste Technologies Announce Partnership to Develop First-in-Class Antibacterial Programme
LONDON, March 16, 2022 /PRNewswire/ -- Oppilotech Ltd, a biotech specialising in systems biology and machine learning platforms to build unique predictive computational models of cells, announces a co-development drug discovery partnership with the UK's Evariste Technologies, which will...


Source:https://www.prnewswire.com:443/news-releases/oppilotech-and-evariste-technologies-announce-partnership-to-develop-first-in-class-antibacterial-programme-301502731.html

Related News
» Multichannel Order Management Market size to Grow by USD 1.43 billion \| Technavio » Digital Financial Exchange Launches New Corporate Identity and A First of Its Kind Program From Dubai